格里亚丁增强了巨细胞应激β细胞触发的巨细胞反应
Tina Zenia Jørgensen1, Knud Josefsen2, Signe Stentoft Dissing1
1The Bartholin Institute, Rigshospitalet, Copenhagen, Denmark; Novo Nordisk, Bagsværd, Denmark.
Cellular immunology
|June 15, 2025
概括
无质饮食可以通过减少细胞压力和免疫激活来有益于1型糖尿病. 谷蛋白是一种谷蛋白成分,直接刺激胰腺β细胞,影响免疫反应和疾病进展.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
背景情况:
- 无质饮食在控制人类和NOD小鼠的1型糖尿病方面表现有前途.
- 贝塔细胞活动和质都会影响自身免疫性糖尿病发病率.
研究的目的:
- 研究素对代谢应激的胰腺细胞和巨细胞的影响.
- 阐明1型糖尿病中无质饮食的益处背后的细胞机制.
主要方法:
- 使用了代谢应激的胰腺细胞系 (MIN6,β TC3,α TC3) 和RAW 264.7巨细胞.
- 评估了格里亚丁对细胞激活,应激反应和免疫调节通路的影响.
主要成果:
- 代谢应激的胰腺细胞激活了巨细胞.
- 格里亚丁在MIN6细胞中增强了这种激活,但在β TC3或α TC3细胞中没有.
- 格里亚丁直接刺激MIN6细胞,影响参与细胞激活,压力和免疫调节的途径.
结论:
- 细胞压力和质蛋白在1型糖尿病的进展中起着重要作用.
- 这些发现支持无质饮食的体内益处,突出显示了gliadin的细胞效应.
相关概念视频
Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K
Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
GPCRs Regulate Adenylyl Cylase Activity
6.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
cAMP-dependent Protein Kinase Pathways
6.7K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K
Glucagon-like Receptor Agonists
438
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
438


